Evergreen Capital Management’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $152K | Sell |
32,325
-9,860
| -23% | -$48.9K | ﹤0.01% | 1486 |
|
|
2026
Q1 | $200K | Sell |
42,185
-8,327
| -16% | -$43.4K | ﹤0.01% | 1405 |
|
|
2025
Q4 | $257K | Sell |
50,512
-7,653
| -13% | -$39.8K | 0.01% | 1133 |
|
|
2025
Q3 | $298K | Buy |
58,165
+28,121
| +94% | +$124K | 0.01% | 979 |
|
|
2025
Q2 | $132K | Sell |
30,044
-18,974
| -39% | -$93.8K | ﹤0.01% | 1076 |
|
|
2025
Q1 | $299K | Buy |
49,018
+17,633
| +56% | +$89.2K | 0.01% | 750 |
|
|
2024
Q4 | $126K | Sell |
31,385
-17,871
| -36% | -$80K | ﹤0.01% | 1036 |
|
|
2024
Q3 | $292K | Sell |
49,256
-7,269
| -13% | -$35.8K | 0.01% | 727 |
|
|
2024
Q2 | $252K | Buy |
56,525
+28,297
| +100% | +$136K | 0.01% | 731 |
|
|
2024
Q1 | $133K | Sell |
28,228
-1,998
| -7% | -$7.65K | 0.01% | 828 |
|
|
2023
Q4 | $153K | Buy |
+30,226
| New | +$148K | 0.01% | 797 |
|
|
2023
Q3 | – | Sell |
-21,270
| Closed | -$202K | – | 830 |
|
|
2023
Q2 | $202K | Buy |
+21,270
| New | +$180K | 0.01% | 728 |
|
|
2023
Q1 | – | Sell |
-468,451
| Closed | -$5.35M | – | 743 |
|
|
2022
Q4 | $5.35M | Buy |
468,451
+40,003
| +9% | +$465K | 0.25% | 116 |
|
|
2022
Q3 | $5.2M | Sell |
428,448
-424,340
| -50% | -$6.43M | 0.27% | 109 |
|
|
2022
Q2 | $13.2M | Buy |
852,788
+842,326
| +8,051% | +$15.2M | 0.68% | 35 |
|
|
2022
Q1 | $221K | Buy |
10,462
+194
| +2% | +$4.18K | 0.01% | 581 |
|
|
2021
Q4 | $243K | Buy |
+10,268
| New | +$220K | 0.01% | 534 |
|
|
2021
Q2 | – | Sell |
-580,663
| Closed | -$12.4M | – | 544 |
|
|
2021
Q1 | $12.4M | Buy |
580,663
+37,838
| +7% | +$814K | 0.63% | 33 |
|
|
2020
Q4 | $11.8M | Buy |
542,825
+20,942
| +4% | +$408K | 0.69% | 32 |
|
|
2020
Q3 | $9.2M | Buy |
521,883
+173,168
| +50% | +$3.22M | 0.64% | 36 |
|
|
2020
Q2 | $6.56M | Buy |
348,715
+13,005
| +4% | +$230K | 0.5% | 52 |
|
|
2020
Q1 | $5.8M | Buy |
+335,710
| New | +$7.02M | 0.54% | 49 |
|
|
2018
Q2 | – | Sell |
-16,775
| Closed | -$218K | – | 389 |
|
|
2018
Q1 | $218K | Sell |
16,775
-251,275
| -94% | -$3.22M | 0.02% | 325 |
|
|
2017
Q4 | $3.69M | Buy |
268,050
+1,050
| +0.4% | +$14.2K | 0.37% | 70 |
|
|
2017
Q3 | $3.51M | Buy |
267,000
+168,750
| +172% | +$2.17M | 0.41% | 65 |
|
|
2017
Q2 | $1.26M | Buy |
98,250
+54,975
| +127% | +$732K | 0.2% | 83 |
|
|
2017
Q1 | $557K | Buy |
43,275
+30,075
| +228% | +$385K | 0.12% | 83 |
|
|
2016
Q4 | $162K | Buy |
13,200
+1,750
| +15% | +$22.6K | 0.03% | 116 |
|
|
2016
Q3 | $169K | Hold |
11,450
| – | – | 0.03% | 108 |
|
|
2016
Q2 | $174K | Buy |
+11,450
| New | +$162K | 0.04% | 95 |
|
|
2016
Q1 | – | Sell |
-387,020
| Closed | -$4.46M | – | 92 |
|
|
2015
Q4 | $4.46M | Buy |
+387,020
| New | +$4.42M | 1.07% | 29 |
|
Other funds holding MPT
WAM
TW
COPPSERS
SOADOR
Evergreen Capital Management's MPT Position: Q2 2026 in Review
Evergreen Capital Management reduced its Medical Properties Trust (MPT) stake by 23% in Q2 2026, selling an estimated $48.9K and leaving 32,325 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.
Evergreen Capital Management first reported a position in MPT in Q4 2015 and has held it in 31 quarters since. The position peaked at $13.2M in Q2 2022. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.
- Evergreen Capital Management held 32,325 shares of Medical Properties Trust worth $152K as of Q2 2026.
- Evergreen Capital Management sold 9,860 Medical Properties Trust shares in Q2 2026, an estimated $48.9K.
- Medical Properties Trust made up ﹤0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1486 holding.
- Evergreen Capital Management first reported a position in Medical Properties Trust in Q4 2015 and has held it in 31 quarters since.
- Evergreen Capital Management's Medical Properties Trust position peaked at $13.2M in Q2 2022.
- 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.